gcanrx symtomax

GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS ACROSS EUROPE, THE MIDDLE EAST AND AFRICA

BALTIMORE, MD – May 7, 2019 — Greater Cannabis Company (OTC: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with European-based Symtomax, a licensed group on medical cannabis cultivation, research and distribution with over 40 years of […]

Continue reading

SYMTOMAX RECEIVES BUILDING PERMIT FOR THEIR GMP FACILITY

Symtomax receives their building permit from the local Portuguese authorities. It was only last June when Symtomax formally applied for their Cultivation license. This coupled with the approval from the local municipality for 95 hectares outdoor cultivation was being seen as a welcome addition to their plans. Chairman Paul Segal stated “This is fantastic news […]

Continue reading